Skyhawk Therapeutics
Latest round
- Seed
Last raised
- Jan 2018
Total raised
- $8M
Investors
- 1
About Skyhawk Therapeutics
Skyhawk Therapeutics, founded in 2016 by Bill Haney, is dedicated to modifying RNA expression for therapeutic purposes.Skyhawk Therapeutics specializes in developing novel small molecules that modify RNA expression, targeting complex diseases in neurology, oncology, and fibrotic diseases. Its core products include SKY-0515, an RNA splicing modulator for Huntington's Disease, and SKY-1300 and SKY-1500 for Spinocerebellar Ataxia Type 3 and Frontotemporal Dementia, respectively.Skyhawk Therapeutics has established a financial foundation exceeding USD 525 mn through strategic partnerships with leading pharmaceutical companies. Its revenue model is primarily B2B, focusing on collaborations for co-developing RNA-targeting therapeutics, involving upfront payments, milestones based on clinical development, and royalties from product sales.00 mn on September 14, 2021, Skyhawk Therapeutics plans to accelerate the development of its RNA-modifying drug candidates into clinical trials. The company aims to expand its product pipeline and enter new markets, including additional regions in Europe and Asia by 2023.
Who invested in Skyhawk Therapeutics
1 investor across 1 round
See all investors in Skyhawk Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 23, 2018
Amount
$8M
Investors
Questions about Skyhawk Therapeutics
Who invested in Skyhawk Therapeutics?
Skyhawk Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Skyhawk Therapeutics raised?
Skyhawk Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Skyhawk Therapeutics last raise money?
Skyhawk Therapeutics's most recent round on record is a Seed, in Jan 2018.
What does Skyhawk Therapeutics do?
Skyhawk Therapeutics, founded in 2016 by Bill Haney, is dedicated to modifying RNA expression for therapeutic purposes.
Where is Skyhawk Therapeutics headquartered?
Skyhawk Therapeutics is headquartered in Waltham, US.
Which VCs invest in companies like Skyhawk Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Skyhawk Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Skyhawk Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.